Affymetrix Launches Microarray Data Analysis Training University
News Oct 18, 2007
Affymetrix Inc. has announced the launch of Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.
Affymetrix University courses provide biologists with a better understanding of how to design their microarray experiments with appropriate quality control, and how to apply statistical methods to interpret biological results effectively. The courses combine hands-on exercises with theoretical presentations and guest speaker seminars.
The first Affymetrix University course will focus on the analysis of gene expression levels using Affymetrix WT (Whole-Transcript) Exon Arrays and 3' IVT (In vitro Transcript) Expression Arrays. The first course will be held in High Wycombe, U.K., November 20-22, 2007. The second course will be held in Santa Clara, Calif., December 4-6, 2007.
Upcoming Affymetrix University data analysis courses will focus on the following microarray applications:
• Copy Number
• Exon/Alternative Splicing
• Integrated Genomic Approaches
“Affymetrix has launched Affymetrix University in response to a growing demand from our customers to help minimize the data analysis bottleneck. Affymetrix University provides an educational forum for biologists to learn more about the essential principles of data analysis involved in successful microarray experiments,” said Rob Clum, market development manager of informatics at Affymetrix.
“With these courses, we are enabling researchers to design studies and access biological data more effectively. This will accelerate research and enable our customers to publish faster than before.”
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.